FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 3842650 · Received February 25, 2014

Report

Report Number
3004464228-2014-00220
Event Type
Malfunction
Date Received
February 25, 2014
Date of Event
January 24, 2014
Report Date
January 24, 2014
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K122953
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION. WE ARE UNABLE TO CONFIRM THE BENT CANNULA OR TO DETERMINE IF IT COULD HAVE CONTRIBUTED TO THE REPORTED HYPERGLYCEMIA. THE CUSTOMER ALSO REPORTED THAT THE CANNULA WAS NOT PROPERLY INSERTED AT THE INFUSION SITE. THIS CONDITION COULD INTERRUPT INSULIN DELIVERY AND CONTRIBUTE TO HYPERGLYCEMIA. LOT QUALIFICATION RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. THE OMNIPOD USER GUIDE WARNS "CHECK THE INFUSION SITE AFTER INSERTION TO ENSURE THAT THE CANNULA WAS PROPERLY INSERTED. THE PDM WILL AUTOMATICALLY REMIND YOU TO CHECK YOUR BLOOD GLUCOSE 1.5 HOURS AFTER EACH POD CHANGE. IF THE CANNULA IS NOT PROPERLY INSERTED, HYPERGLYCEMIA MAY RESULT. VERIFY THERE IS NO WETNESS OR SCENT OF INSULIN, WHICH MAY INDICATE THE CANNULA HAS DISLODGED," AND "TEST RESULTS GREATER THAN 250 ML/DL MEAN HIGH BLOOD GLUCOSE (HYPERGLYCEMIA). IF YOU GET RESULTS ABOVE 250 MG/DL, BUT DO NOT HAVE SYMPTOMS OF HYPERGLYCEMIA, REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL ABOVE 250 MG/DL, FOLLOW THE TREATMENT ADVISE OF YOUR HEALTHCARE PROVIDER."

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT THE CANNULA DID NOT DEPLOY PROPERLY AND THE CANNULA DID NOT INSERT AT THE INSERTION SITE. THE CUSTOMER ALSO REPORTED THAT THE CANNULA WAS BENT. THE CUSTOMER SAID THAT HER BLOOD GLUCOSE REACHED 318 MG/DL, AND THAT INSULIN WAS LEAKING OUT OF THE POD. THE POD WAS WORN BETWEEN 4 AND 24 HOURS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
114875 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 114000 L40785

Patients

Seq Age Sex Outcome Treatment
1 24 YR